These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
206 related articles for article (PubMed ID: 1831226)
21. Immunization with outer membrane proteins (OprF and OprI) and flagellin B protects mice from pulmonary infection with mucoid and nonmucoid Pseudomonas aeruginosa. Hassan R; El-Naggar W; Abd El-Aziz AM; Shaaban M; Kenawy HI; Ali YM J Microbiol Immunol Infect; 2018 Jun; 51(3):312-320. PubMed ID: 28291719 [TBL] [Abstract][Full Text] [Related]
22. Human monoclonal antibodies against Pseudomonas aeruginosa lipopolysaccharide derived from transgenic mice containing megabase human immunoglobulin loci are opsonic and protective against fatal pseudomonas sepsis. Hemachandra S; Kamboj K; Copfer J; Pier G; Green LL; Schreiber JR Infect Immun; 2001 Apr; 69(4):2223-9. PubMed ID: 11254577 [TBL] [Abstract][Full Text] [Related]
23. Anti-idiotype-induced, lipopolysaccharide-specific antibody response to Pseudomonas aeruginosa. II. Isotype and functional activity of the anti-idiotype-induced antibodies. Schreiber JR; Nixon KL; Tosi MF; Pier GB; Patawaran MB J Immunol; 1991 Jan; 146(1):188-93. PubMed ID: 1898598 [TBL] [Abstract][Full Text] [Related]
24. Idiotype vaccine against Hodgkin's lymphoma: generation and characterization of an anti-idiotypic monoclonal antibody against the Hodgkin-associated (anti-CD 30) monoclonal antibody HRS-3. Pohl C; Sieber M; Diehl V; Pfreundschuh M Anticancer Res; 1991; 11(3):1115-24. PubMed ID: 1653553 [TBL] [Abstract][Full Text] [Related]
25. Role of alginate O acetylation in resistance of mucoid Pseudomonas aeruginosa to opsonic phagocytosis. Pier GB; Coleman F; Grout M; Franklin M; Ohman DE Infect Immun; 2001 Mar; 69(3):1895-901. PubMed ID: 11179370 [TBL] [Abstract][Full Text] [Related]
26. Opsonic and protective activity of five human IgM monoclonal antibodies reactive with lipopolysaccharide antigen of Pseudomonas aeruginosa. Collins MS; Ladehoff DK; Mehton NS; Noonan JS FEMS Microbiol Immunol; 1990 Dec; 2(5-6):263-8. PubMed ID: 2127368 [TBL] [Abstract][Full Text] [Related]
27. Nonopsonic antibodies in cystic fibrosis. Pseudomonas aeruginosa lipopolysaccharide-specific immunoglobulin G antibodies from infected patient sera inhibit neutrophil oxidative responses. Eichler I; Joris L; Hsu YP; Van Wye J; Bram R; Moss R J Clin Invest; 1989 Dec; 84(6):1794-804. PubMed ID: 2512330 [TBL] [Abstract][Full Text] [Related]
32. Contribution of humoral and cellular factors to the resistance to experimental infection by Pseudomonas aeruginosa in mice. II. Opsonic, agglutinative, and protective capacities of immunoglobulin G anti-Pseudomonas antibodies. Bjornson AB; Michael JG Infect Immun; 1972 May; 5(5):775-82. PubMed ID: 4629252 [TBL] [Abstract][Full Text] [Related]
33. Idiotypic cascades after injection of the monoclonal antibody OC125: a study in a mouse model. Induction of antibodies against OC125 and CA125 after immunization with an anti-CA 125 (MAb OC125) monoclonal antibody by activation of the idiotypic network. Schultes BC; Reinsberg J; Schlebusch H; Oehr P; Biersack HJ; Krebs D; Wagner U Eur J Clin Chem Clin Biochem; 1993 Jul; 31(7):427-32. PubMed ID: 8399782 [TBL] [Abstract][Full Text] [Related]
34. Bispecific antibodies overcome the opsonin-receptor mismatch of cystic fibrosis in vitro: restoration of neutrophil-mediated phagocytosis and killing of Pseudomonas aeruginosa. McCormick LL; Karulin AY; Schreiber JR; Greenspan NS J Immunol; 1997 Apr; 158(7):3474-82. PubMed ID: 9120309 [TBL] [Abstract][Full Text] [Related]
35. Human monoclonal antibodies to Pseudomonas aeruginosa alginate that protect against infection by both mucoid and nonmucoid strains. Pier GB; Boyer D; Preston M; Coleman FT; Llosa N; Mueschenborn-Koglin S; Theilacker C; Goldenberg H; Uchin J; Priebe GP; Grout M; Posner M; Cavacini L J Immunol; 2004 Nov; 173(9):5671-8. PubMed ID: 15494518 [TBL] [Abstract][Full Text] [Related]
36. Role of anti-pilus antibodies in host defense against gonococcal infection studied with monoclonal anti-pilus antibodies. Virji M; Heckels JE Infect Immun; 1985 Sep; 49(3):621-8. PubMed ID: 2411660 [TBL] [Abstract][Full Text] [Related]
37. Studies on phagocytosis of mucoid and nonmucoid variants of Pseudomonas aeruginosa. II. Induction of heterologous immunity by mucoid strains of P. aeruginosa. Gościniak G; Grzybek-Hryncewicz K Arch Immunol Ther Exp (Warsz); 1988; 36(2):185-93. PubMed ID: 3149177 [TBL] [Abstract][Full Text] [Related]
38. Complex serology and immune response of mice to variant high-molecular-weight O polysaccharides isolated from Pseudomonas aeruginosa serogroup O2 strains. Hatano K; Pier GB Infect Immun; 1998 Aug; 66(8):3719-26. PubMed ID: 9673254 [TBL] [Abstract][Full Text] [Related]
39. Mucoid Pseudomonas aeruginosa resists nonopsonic phagocytosis by human neutrophils and macrophages. Cabral DA; Loh BA; Speert DP Pediatr Res; 1987 Oct; 22(4):429-31. PubMed ID: 2891100 [TBL] [Abstract][Full Text] [Related]
40. Role of Pseudomonas aeruginosa mucoid exopolysaccharide in adherence to tracheal cells. Ramphal R; Pier GB Infect Immun; 1985 Jan; 47(1):1-4. PubMed ID: 3155514 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]